BridgeBio Submits NDA to FDA for Encaleret for Individuals Living with ADH1
Go back to BridgeBio Submits NDA to FDA for Encaleret for Individuals Living with ADH1| (NASDAQ: BBIO) | Delayed: 69.36 +0.73 (1.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $68.63 | 52 Week High | $ | |||
| Open | $69.25 | 52 Week Low | $ | |||
| Day High | $70.77 | P/E | N/A | |||
| Day Low | $68.94 | EPS | $ | |||
| Volume | 4,190,473 | |||||
